Decide at what price you'd be comfortable buying and we'll help you stay ready.
AIA is a large, capital-intensive life insurer whose revenue and premium volumes can grow while reported earnings move materially with insurance-service, investment and currency effects. Its balance sheet is dominated by invested assets and policy liabilities, while recurring capital generation supports dividends and buybacks that have reduced the share base.
The latest annual results show revenue growth continuing, but reported operating income and common net income both declined versus 2024. This is a meaningful profitability development, but not yet a confirmed change in the long-term model because AIA continued to report broad-based new-business growth and recurring earnings generation.
Whether revenue growth is accompanied by operating-margin recovery without another adverse non-operating investment or tax effect.
| Metric | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| 20.6B | 25.7B | 29.7B | 32.9B | 33.7B | 34.8B | 34.3B | 17.6B | 19.3B | 21.7B | |
| 28B | 38.7B | 32.2B | 47.5B | 50.3B | 46.8B | 19.6B | 19.9B | 22.7B | ||
| (22.9B) | (31.1B) | (28.2B) | (39.8B) | (42.5B) | (37.6B) | (18.3B) | (14.4B) | (14.6B) | (18.8B) | |
| (1.6B) | (1.8B) | (2B) | (2.2B) | (2.3B) | (2.6B) | (2.6B) | — | — | — | |
| (122m) | (140m) | (162m) | (339m) | (389m) | (394m) | (404m) | — | — | — | |
| (23B) | (30.5B) | (28.2B) | (38.6B) | (40.3B) | (35.7B) | (15.2B) | (12.1B) | (13.1B) | (14.2B) | |
| 2.1B | 2.2B | 2.5B | 2.2B | 1.2B | 1.1B | 1.2B | — | — | — | |
| (150m) | (856m) | (296m) | (850m) | (586m) | (6m) | (1.3B) | (2.4B) | (1.5B) | (4.6B) | |
| 5.1B | 7.6B | 4B | 7.8B | 7.9B | 9.2B | 1.3B | 5.5B | 8.1B | ||
| (154m) | (183m) | (212m) | (291m) | (309m) | (368m) | (426m) | (730m) | (219m) | (116m) | |
| 149m | 183m | 212m | 283m | 292m | 357m | — | — | — | — | |
| (104m) | (142m) | (285m) | (246m) | (285m) | (338m) | (360m) | (195m) | (16m) | (29m) | |
| 4.9B | 7.3B | 3.5B | 7.2B | 7.3B | 8.5B | 491m | 4.6B | 7.8B | 7.5B | |
| (660m) | (1.1B) | (849m) | (1.2B) | (1.5B) | (991m) | (171m) | (783m) | (978m) | (1.2B) | |
| 4.2B | 6.2B | 2.7B | 6B | 5.8B | 7.5B | 320m | 3.8B | 6.9B | 6.3B | |
| (48m) | (67m) | (62m) | (39m) | 0 | (50m) | (38m) | (17m) | (17m) | (33m) | |
| 4.2B | 6.1B | 2.6B | 6B | 5.8B | 7.4B | 282m | 3.8B | 6.8B | ||
| 0.35 | 0.51 | 0.22 | 0.50 | 0.48 | 0.61 | 0.02 | 0.33 | 0.62 |
Alpha Spread
Preferences
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
New to Alpha Spread? Create free account
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Already have an account? Sign in
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more